Department of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse (IUCT)-Oncopole, 1 Avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France.
Department of Gynecology and Obstetrics, Centre Hospitalier Intercommunal Des Vallées de L'Ariège, St Jean de Verges, France.
Arch Gynecol Obstet. 2021 May;303(5):1295-1304. doi: 10.1007/s00404-020-05874-y. Epub 2021 Jan 3.
The aim of our study was to assess concordance of staging laparoscopy and cytoreductive surgery (CRS) peritoneal cancer index (PCI) when applying a two-step surgical protocol. We also aimed to evaluate the accuracy of diagnostic laparoscopy to triage patients for complete cytoreduction, and to define optimal time between staging laparoscopy and CRS.
We designed a retrospective review of prospectively collected data from patients with advanced ovarian cancer who underwent a diagnostic laparoscopy followed by a CRS a few weeks later (two-step surgical protocol), from January 2010 to April 2019. Only patients selected for complete cytoreduction, and with available PCI score from both surgeries were included. PCI concordance was assessed using intraclass correlation coefficient (ICC).
During the study period 543 patients underwent a laparoscopic staging for ovarian carcinomatosis. Among them, 43 patients fulfilled inclusion criteria. ICC between laparoscopic and laparotomic PCI was 0.54. After applying the linear regression equation: laparoscopic PCI + 0.2 x [days between surgeries] + 2, ICC increased to 0.79. Completeness cytoreduction score and laparoscopic PCI were significantly associated (OR 1.27, 95% CI 1.03-1.57, p = 0.03). AUC of laparoscopic PCI to predict complete cytoreduction was 0.90.
Concordance between laparoscopic PCI assessment and PCI score at the end of CRS is fair within a two-step surgical management. Laparoscopic assessment underestimates final PCI score by two points, and this difference increases with the delay between both surgeries. Diagnostic laparoscopy can adequately select patients for CRS, and optimal time to perform it is no more than 10 days after laparoscopy.
本研究旨在评估两步式手术方案中分期腹腔镜检查和细胞减灭术(CRS)腹膜癌指数(PCI)的一致性。我们还旨在评估诊断腹腔镜检查对完全细胞减灭术患者进行分类的准确性,并确定分期腹腔镜检查和 CRS 之间的最佳时间。
我们设计了一项回顾性研究,对 2010 年 1 月至 2019 年 4 月期间接受诊断性腹腔镜检查和数周后进行 CRS 的晚期卵巢癌患者的前瞻性收集数据进行回顾性分析(两步式手术方案)。仅包括选择进行完全细胞减灭术且两次手术均有 PCI 评分的患者。使用组内相关系数(ICC)评估 PCI 一致性。
在研究期间,543 例患者接受了腹腔镜分期卵巢癌转移。其中,43 例符合纳入标准。腹腔镜和剖腹式 PCI 的 ICC 为 0.54。应用线性回归方程:腹腔镜 PCI+0.2x[手术间隔天数]+2 后,ICC 增加至 0.79。完全细胞减灭评分和腹腔镜 PCI 显著相关(OR 1.27,95%CI 1.03-1.57,p=0.03)。腹腔镜 PCI 预测完全细胞减灭的 AUC 为 0.90。
两步式手术管理中,腹腔镜 PCI 评估与 CRS 结束时 PCI 评分之间的一致性为中等。腹腔镜评估比最终 PCI 评分低 2 分,并且这种差异随两次手术之间的延迟而增加。诊断性腹腔镜检查可以充分选择适合 CRS 的患者,进行手术的最佳时间不超过腹腔镜检查后 10 天。